ArticleTranslational cancer research2025
When is belzutifan the right option for von Hippel-Lindau disease-associated hemangioblastomas?-a critical review of LITESPARK-004 results.
Ugur Sener et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.